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ABSTRAK
Asam urat sebagai hasil akhir dari metabolisme purin basa. Dalam kondisi tingkat tinggi, asam urat 
memasuki sel dan bertindak sebagai oksidan, kemudian bertindak sebagai faktor risiko independen dan 
memprediksi kejadian diabetes melitus tipe 2 (T2DM). Ini dapat langsung menonaktifkan atau melalui reaksi 
oksidatif yang menurunkan tingkat oksida nitrat (NO). Level NO yang lebih rendah akan mengurangi penyerapan 
insulin dalam jaringan dan mengurangi translokasi GLUT4 dalam sel yang akan mempengaruhi kadar gula 
darah. Tingginya kadar asam urat atau hyperuricemia membuat stres oksidatif dengan menginduksi produksi 
spesies oksigen reaktif (ROS) yang mengganggu jalur persinyalan insulin, menciptakan keadaan peradangan 
yang mengurangi sensitivitas insulin, serapan glukosa darah dan metabolisme, juga mengurangi produksi 
insulin dari sel islet pankreas.
Kata kunci: kadar asam urat, nitric oxide (NO), stres oksidatif, gula darah.
ABSTRACT
Uric acid as the final result of purine bases metabolism. In high level condition, uric acid enters the cell 
and act as oxidant, and acts as independent risk factor and predicts the incident of type 2 diabetes mellitus 
(T2DM). It may directly inactivate or through oxidative reaction that lower the nitric oxide (NO) level. Lower 
NO level will reduce insulin uptake in tissues and reduce in GLUT4 translocation in cell that will effect the blood 
glucose level. The High level of uric acid or hyperuricemia makes oxidative stress by inducing the production 
of reactive oxygen species (ROS) which interferes the insulin signalling pathway,creates inflammatory  state 
that reduced the insulin sensitivity,blood glucose uptake and metabolism, also reducing the insulin production 
from pancreatic islet cells.
Keywords: uric acid levels, nitric oxide (NO), oxidative stress, blood glucose.
INTRODUCTION
Uric acid is a diprotic acid a result of final 
breakdown product of purine bases metabolism. 
Normal reference of uric acif in human blood 
is 1.5-6 mg/dL in women and 2.5-7 mg/dL 
in men. Outside cell environment, it acts as 
antioxidant, scavenging oxygen peroxyl or ROS 
and hydroxyl (OH) radicals.1-3 Several evidences 
from epidemiological studies that serum uric acid 
level is an idependent risk factor and predicts a 
17% increment in the risk of T2DM.3-4 Insulin 
can stimulate the urate-anion exchanger in the 
brush border membranes of renal proximal 
tubules and raise the renal urate reabsorption. 
This proccess makes the serum uric acid levels 
increased along with increase level of blood 
Wardhana                                                                                                                     Acta Med Indones-Indones J Intern Med
254
glucose levels reflected on the glycohaemoglobin 
levels (HbA1C) less than 7% but then decresed 
with further increament of HbA1C level more 
than 7%, and it makes a bell-shape relation.5
High level, uric acid enters cell through 
specific anion transporters, inducing oxidative 
streess by stimulating nicotinamide adenine 
dinucleotide phosphate-oxidase (NADPH 
oxidase) which results in increased production 
of ROS, and direct inactivation of NO.3 Uric acid 
is reported to induce insulin resistance. One of 
the theory, it may reduce the bioavailability of 
NO, which is important for insulin-stimulated 
glucose uptake in skeletal muscles, and also 
induces inflammation.6
URIC ACID’S EFFECTS ON NITRIC OXIDE 
AND BLOOD GLUCOSE
Nitric oxide at low dose may promote insulin 
uptake since it causes dilatation of both resistant 
and terminal arterioles in skeletal muscle in vivo. 
Increased concentration of uric acid may cause 
direct inactivation of NO by changing it into 
6-aminouracil, and reduced the insulin uptake.7 
Nitric oxide may induce the cyclic guanosine 
mono phosphate (cGMP) formation using 
granulate cyclase, increasing glucose uptake 
(cGMP-dependent pathway). The formation of 
cGMP may activate protein kinase G (PKG). 
The activation of PKG is likely to be associated 
with GLUT4 translocation which is raising 
the glucose uptake. The reduction in NO level 
by ROS produced by uric acid condition will 
reduce the GLUT4 translocation and the glucose 
uptake.8 (Figure 1)
The ROS as well as peroxynitrite (ONOO) 
producing a reaction between superoxide 
anion (O
2
-) with NO, inducing degradation of 
the cofactor of nitric oxyde synthase (NOS), 
tetrahydrobiopterin (BH4), causes uncoupling of 
endothelial NOS then reduce the bioavailability 
of NO. Peroxynitrite is an oxidant that oxidizes 
lipids, proteins, nitrated amino acids and DNA.9-11
OXIDATIVE STRESS CAUSED BY URIC 
ACID AND ITS EFFECT ON BLOOD 
GLUCOSE
Uric acid may disturb the glucose and insulin 
tolerances through oxidative stress by inducing 
ROS production through NADPH oxidase 
stimulation.4 Xanthine oxidase in the formation 
of uric acid may also produce ROS. Uric acid 
directly increased the phosphorylated insulin 
receptor substrate 1 (IRS1, Ser307) and phospho-
Akt (Ser473),inducing insulin resistance.12 Uric 
acid may activate NADPH oxidase to produce 
ROS, consists of  O2- dan hydrogen peroxide 
(H2O2).4,13 All protein tyrosine phosphatases 
share a common structure with a catalytically 
essential cyctein residue in the active centre 
that has catalytic activity. It may be inactivated 
either by reaction with H
2
O
2
 into sulfenic acid 
derivative or by reaction with glutathione 
disulfide through glutathiolation proccess of 
critical cystein residue.13 The ROS may attenuate 
insulin signaling,involving the redox-sensitive 
and insensitive serine kinases (SerKs) by 
reducing IRS1 signalling to phosphatidylinositol 
3 kinase (PI3K).14
The ROS may also activate redox-
dependent activation of the proinflammatory 
signalling through p38 mitogen activated 
protein (MAP) kinase and nuclear transcription 
factor, nuclear factor kappa-beta (NF-κβ) and 
activator protein-1 (AP-1) as transcription factor, 
then followed by the increase production of 
monocyte chemoattractant protein-1 (MCP-1), 
and may induce apoptosis.14-15 The MCP-1 has an 
important role in the recruitment of monocytes 
contributing in initiation and inflammation 
reactions.
Uric acid may also induce mononuclear cells 
to produced interleukin-1β (IL-1β), interleukin-6 
(IL-6), and tumor necrosis factor-α (TNF-α), 
but the most important pro-inflammatory 
mediators involved in inflammation are IL-6 
Figure 1. Nitric oxide increases GLUT4 translocation and 
glucose uptake. Uric acid may directly change NO into 
inactive form. ROS may degradate the cofactor of NOS, 
reducing NO bioavailability.
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and  TNF-α.15-16 The IL-6  activates Src (proto-
oncogene tyrosine-protein kinase)-homology 2 
domain (SH2)-containing: SHP-2, and signal 
transducer and activator of transcription 3 
(STAT3) resulting in increased expression of 
cytokine signalling 3 (SOCS3). The IL-6 also 
activate several serine/threonine kinases such 
c-Jun N-terminal kinases (JNK), p38MAPK, 
and PKC-δ wich contributes in reducing insulin 
sensitivity and glucose metabolism. The TNF-α 
causes insulin resistance by suppressing IRS-
1 associated insulin signalling and glucose 
transport in skeletal muscle.16
Uric Acid may stimulate receptor for 
advanced glycation end products (RAGE) 
as a transmembrane multiligand receptor of 
the immunoglobulin superfamily which has 
been implicated in many chronic diseases and 
also inflammation. After the RAGE signaling 
pathway is stimulated, then the NF-κβ will 
be activated, resulting in the production and 
release of pro-inflammatory cytokines, and 
also increasing the expression and extracellular 
release of high mobility group box chromosomal 
protein 1 (HMGB1) that causes the amplification 
of inflammatory response.17 (Figure 2)
Uric acid also may decrease glucose-
stimulated insulin secretion from pancreatic 
islet cells. Insulin biosynthesis is regulated by 
two main transcription factors, pancreatic and 
duodenal homeobox-1 (PDX-1) and mafA which 
bind to their promoter region. It is known that p38 
MAPK and JNK which are activated by ROS, 
are also available in pancreatic islet cells and the 
amount and activity of c-Jun phosphorylated by 
JNK are also raise in number by ROS. The c-Jun 
may interfere the insulin transcription proccess 
at the promotor region by translocating PDX-
1 from nucleus into cytoplasm and decrease 
of posttranslational mafA protein level.18 The 
mafA is also degradated using proteosomal 
system and it is enhanced in the uric acid-treated 
cells, and makes the decreased of insulin gene 
expression,insulin production, and insulin 
secretion.19 (Figure 3)
CONCLUSION
Uric acid may have an effect on blood 
glucose levels, disturbing glucose metabolism 
and also insulin sensitivity and production. 
In hyperuricemia,uric acid may enter the 
cells and becomes oxidant. It may reduce the 
bioavailability of NO, as the result there are 
a reduction  the in synthesis, inactivation, 
including reduced the translocation of GLUT4. 
The hyperuricemia condition may induce 
Figure 2. Uric acid is causing oxidative stress and reducing insulin production,secretion, and sensitivity.
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oxidative stress that disturbing the insulin 
signalling pathway, inducing inflammation with 
insulin resistance as the result, also reducing the 
production and secretion of insulin.
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